8,9-Dimethoxy-5-{[(2-methylphenyl)methyl]sulfanyl}-3-(propan-2-yl)-2H,3H-imidazo[1,2-c]quinazolin-2-one

Catalog No. :
ACNMKC808
CAS No. :
920529-89-1
Molecular Formula :
C23H25N3O3S
Molecular Weight :
423.54

IUPAC Name:3-isopropyl-8,9-dimethoxy-5-((2-methylbenzyl)thio)imidazo[1,2-c]quinazolin-2(3H)-one

8,9-Dimethoxy-5-{[(2-methylphenyl)methyl]sulfanyl}-3-(propan-2-yl)-2H,3H-imidazo[1,2-c]quinazolin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$341.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8,9-Dimethoxy-5-{[(2-methylphenyl)methyl]sulfanyl}-3-(propan-2-yl)-2H,3H-imidazo[1,2-c]quinazolin-2-one
IUPAC Name3-isopropyl-8,9-dimethoxy-5-((2-methylbenzyl)thio)imidazo[1,2-c]quinazolin-2(3H)-one
MDL No.MFCD02571442
Molecular FormulaC23H25N3O3S
Molecular Weight423.54
SMILESO=C(C1C(C)C)N=C2N1C(SCC3=CC=CC=C3C)=NC4=C2C=C(OC)C(OC)=C4
InChI KeyKRYIEDFHWXJXGF-UHFFFAOYSA-N
Synonym3-ISOPROPYL-8,9-DIMETHOXY-5-[(2-METHYLBENZYL)SULFANYL]IMIDAZO[1,2-C]QUINAZOLIN-2(3H)-ONE;8,9-dimethoxy-5-{[(2-methylphenyl)methyl]sulfanyl}-3-(propan-2-yl)-2H,3H-imidazo[1,2-c]quinazolin-2-one;Imidazo[1,2-c]quinazolin-2(3H)-one, 8,9-dimethoxy-3-(1-methylethyl)-5-[[(2-methylphenyl)methyl]thio]-
CAS No.920529-89-1

Synthetic Route by SureRoute

1. ACNMKC808 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNMKC808 route product structure diagram
    ACNMKC808920529-89-1
Inquiry

2. ACNMKC808 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNMKC808 route product structure diagram
    ACNMKC808920529-89-1
Inquiry

Comments (0)